<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00860704</url>
  </required_header>
  <id_info>
    <org_study_id>EK 299/2006</org_study_id>
    <nct_id>NCT00860704</nct_id>
  </id_info>
  <brief_title>Goal Directed Fluid Therapy</brief_title>
  <acronym>FLO1</acronym>
  <official_title>Intraoperative Goal Directed Fluid Therapy in Lean and Obese Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intraoperative fluid demand will be monitored by Esophageal Doppler in lean and obese
      patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To our knowledge no data are available on the effect of goal-directed fluid therapy on
      hemodynamics in lean patients and obese patients, respectively. Consequently, we want to
      compare lean patients (BMI &lt;25) vs. obese patients (BMI &gt;25) in regard of their respective
      needs for intraoperative fluid therapy, and the impact of the goal-directed fluid regimen on
      tissue oxygenation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2007</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>different hemodynamic fluid responses in the different groups</measure>
    <time_frame>every 10 minutes during surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subcutaneous oxygen tension (PsqO2)</measure>
    <time_frame>every 10 minutes during surgery and 2 hours postoperatively</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Goal Directed Fluid Therapy</condition>
  <arm_group>
    <arm_group_label>crystalloids lean</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>fluidotherapy with crystalloids in lean patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>crystalloids obese</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>fluidotherapy with crystalloids in obese patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>fluidotherapy with ringer-lactate</intervention_name>
    <description>a bolus of 250ml ringer-lactate is administered, if there is fluid demand monitored by the Esophageal Doppler</description>
    <arm_group_label>crystalloids lean</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>fluidotherapy with ringer-lactate</intervention_name>
    <description>a bolus of 250ml ringer-lactate is administered, if there is fluid demand monitored by the Esophageal Doppler</description>
    <arm_group_label>crystalloids obese</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  female patients (18 - 80 years) undergoing elective gynecological open surgery
             (hysterectomy, ovarian cysts and tumors, myomectomy, endometriosis)

        Exclusion Criteria:

          -  cardiac insufficiency (EF&lt; 35%)

          -  renal insufficiency (creatinin clearance &lt;30ml/min, dialysis)

          -  insulin dependant diabetes mellitus

          -  coagulopathy

          -  NYHA IV

          -  infection

          -  sepsis

          -  history of suspect malignant hyperthermia

          -  porphyria
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrea Holzer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University Vienna, Department of Anesthesiology and General Intensive Care Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <reference>
    <citation>Gan TJ, Soppitt A, Maroof M, el-Moalem H, Robertson KM, Moretti E, Dwane P, Glass PS. Goal-directed intraoperative fluid administration reduces length of hospital stay after major surgery. Anesthesiology. 2002 Oct;97(4):820-6.</citation>
    <PMID>12357146</PMID>
  </reference>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 11, 2009</study_first_submitted>
  <study_first_submitted_qc>March 11, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 12, 2009</study_first_posted>
  <last_update_submitted>April 6, 2015</last_update_submitted>
  <last_update_submitted_qc>April 6, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 7, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Andrea Holzer</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>goal directed fluid therapy</keyword>
  <keyword>lean patients</keyword>
  <keyword>obese patients</keyword>
  <keyword>crystalloids</keyword>
  <keyword>Esophageal Doppler</keyword>
  <keyword>tissue oxygenation</keyword>
  <keyword>Fluid management during surgery</keyword>
  <keyword>Fluid management</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

